WORLD PEPTIDEFOUNDATION
← Master Registry

Non-peptide comparator · published research references

Anamorelin

Governed scientific comparator

2 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

This reference comparator is not classified as a peptide.

Approved source records

  1. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials.

    DOI: 10.1016/s1470-2045(15)00558-6

    Source identity and connection checked by Codex (AI).

  2. Anamorelin in the Management of Cancer Cachexia: Clinical Efficacy, Challenges, and Future Directions.

    DOI: 10.21873/anticanres.17475

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Garcia JM
  • Temel JS
  • Abernethy AP
  • Currow DC
  • Friend J
  • Duus EM
  • Yan Y
  • Fearon KC
  • Prommer E
  • Fujii H
  • Yamada Y
  • Iihara H
  • Kobayashi R
  • Suzuki A